Anifrolumab Treatment Prevents Long-Term Oral Corticosteroid-Related, Ocular, and Musculoskeletal Organ Damage Accrual Compared With Real-World Standard of Care in Patients With Systemic Lupus Erythematosus: Findings From the LASER Study